Monoclonal Anti-Pan cytokeratin, PCK
To Order Contact us: lieven@wlsolutions.be
Anti-Cytokeratin, pan (Epithelial Marker) Monoclonal Antibody |
||
| M14209-2 | 100ug/vial | EUR 476.4 |
|
Description: Mouse Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody. Validated in IHC and tested in Bovine, Canine, Chicken, Human, Monkey, Mouse, Rabbit, Rat. |
||
anti-Cytokeratin (Pan) (7H8C4) |
||
| LF-MA30121 | 100 ul | EUR 583.2 |
|
Description: Mouse Monoclonal to Cytokeratin (Pan) |
||
anti-Cytokeratin(Pan) (7H8) |
||
| LF-MA30276 | 100 ul | EUR 583.2 |
|
Description: Mouse Monoclonal to Cytokeratin(Pan) |
||
Anti-Cytokeratin, Pan antibody |
||
| STJ180154 | 0.1 ml | EUR 254.4 |
Anti-Cytokeratin, Pan antibody |
||
| STJ180390 | 0.1 ml | EUR 276 |
Anti-Cytokeratin (Pan) antibody |
||
| STJ97993 | 100 µl | EUR 280.8 |
|
Description: Mouse monoclonal to Cytokeratin (Pan). |
||
Anti-Cytokeratin (Pan) antibody |
||
| STJ97994 | 100 µl | EUR 280.8 |
|
Description: Mouse monoclonal to Cytokeratin (Pan). |
||
Monoclonal Cytokeratin(Pan) Antibody, Clone: 7H8 |
||
| AMM05824G | 0.1ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Cytokeratin(Pan). The antibodies are raised in Mouse and are from clone 7H8. This antibody is applicable in IHC, ICC, E |
||
Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody, Clone: PAN-CK (Cocktail) |
||
| APR14636G | 7 ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Cytokeratin, pan (Epithelial Marker). The antibodies are raised in Mouse and are from clone PAN-CK (Cocktail). This antibody is applicable in WB, IHC and IF, FC |
||
pan-Cytokeratin antibody |
||
| 23032-100ul | 100ul | EUR 468 |
pan Cytokeratin antibody |
||
| 10R-2060 | 100 ul | EUR 483.6 |
|
Description: Mouse monoclonal pan Cytokeratin antibody |
||
Cytokeratin Pan antibody |
||
| 10R-2096 | 100 ul | EUR 483.6 |
|
Description: Mouse monoclonal Cytokeratin Pan antibody |
||
Anti-Cytokeratin, pan (Epithelial Marker) Antibody |
||
| M14209-3 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Polyclonal Cytokeratin, pan (Epithelial Marker) Antibody. Validated in IHC and tested in Human. |
||
Anti-Cytokeratin, pan (Epithelial Marker) Antibody |
||
| M30944 | 100ug/vial | EUR 476.4 |
|
Description: Mouse Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody. Validated in IHC and tested in Bovine, Canine, Chicken, Human, Monkey, Mouse, Rabbit, Rat. |
||
Anti-Cytokeratin-pan (Acetyl K194) antibody |
||
| STJ90157 | 200 µl | EUR 236.4 |
|
Description: Rabbit polyclonal to Acetyl-Cytokeratin-pan (K194). |
||
Cytokeratin (Pan-reactive) Antibody |
||
| abx140242-01mg | 0.1 mg | EUR 427.2 |
Pan Cytokeratin Antibody Cocktail |
||
| V9361-100UG | 100ug | EUR 499 |
|
Description: PCK/4933R demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, PCK/4933R is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, PCK/4933R is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail |
||
| V9361-20UG | 20ug | EUR 219 |
|
Description: PCK/4933R demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, PCK/4933R is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, PCK/4933R is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail |
||
| V9361SAF-100UG | 100ug | EUR 499 |
|
Description: PCK/4933R demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, PCK/4933R is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, PCK/4933R is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail |
||
| V9362-100UG | 100ug | EUR 499 |
|
Description: Anti-cytokeratin clone rPCK/6750 demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, rPCK/6750 is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, rPCK/6750 is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail |
||
| V9362-20UG | 20ug | EUR 219 |
|
Description: Anti-cytokeratin clone rPCK/6750 demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, rPCK/6750 is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, rPCK/6750 is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail |
||
| V9362SAF-100UG | 100ug | EUR 499 |
|
Description: Anti-cytokeratin clone rPCK/6750 demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, rPCK/6750 is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, rPCK/6750 is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody, Clone: SPM115 + SPM116 |
||
| APR14633G | 7 ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Cytokeratin, pan (Epithelial Marker). The antibodies are raised in Mouse and are from clone SPM115 + SPM116. This antibody is applicable in WB, IHC and IF, FC |
||
Cytokeratin, pan (Epithelial Marker); Clone PAN-CK (Concentrate) |
||
| RA0430-C.5 | 0.5 ml | EUR 360 |
Human Pan cytokeratin ELISA kit |
||
| E01P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Human Pan cytokeratin ELISA kit |
||
| E01P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Human Pan cytokeratin ELISA kit |
||
| E01P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Goat Pan cytokeratin ELISA kit |
||
| E06P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Goat Pan cytokeratin ELISA kit |
||
| E06P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Goat Pan cytokeratin ELISA kit |
||
| E06P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Dog Pan cytokeratin ELISA kit |
||
| E08P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Dog Pan cytokeratin ELISA kit |
||
| E08P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Dog Pan cytokeratin ELISA kit |
||
| E08P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rabbit Pan cytokeratin ELISA kit |
||
| E04P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rabbit Pan cytokeratin ELISA kit |
||
| E04P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rabbit Pan cytokeratin ELISA kit |
||
| E04P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Pig Pan cytokeratin ELISA kit |
||
| E07P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Pig Pan cytokeratin ELISA kit |
||
| E07P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Pig Pan cytokeratin ELISA kit |
||
| E07P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Mouse Pan cytokeratin ELISA kit |
||
| E03P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Mouse Pan cytokeratin ELISA kit |
||
| E03P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Mouse Pan cytokeratin ELISA kit |
||
| E03P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rat Pan cytokeratin ELISA kit |
||
| E02P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rat Pan cytokeratin ELISA kit |
||
| E02P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rat Pan cytokeratin ELISA kit |
||
| E02P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Cytokeratin (Pan-reactive) Antibody (PE) |
||
| abx140315-01mg | 0.1 mg | EUR 627.6 |
Cytokeratin (Pan-reactive) Antibody (APC) |
||
| abx140316-01mg | 0.1 mg | EUR 627.6 |
Cytokeratin (Pan-reactive) Antibody (Biotin) |
||
| abx140317-01mg | 0.1 mg | EUR 510 |
Cytokeratin (Pan-reactive) Antibody (FITC) |
||
| abx140318-01mg | 0.1 mg | EUR 560.4 |
Cytokeratin (Pan) (CK-5) Antibody |
||
| abx015732-100ul | 100 ul | EUR 493.2 |
Cytokeratin (Pan) (CK-5) Antibody |
||
| abx015736-100ul | 100 ul | EUR 493.2 |
Monkey Pan cytokeratin ELISA kit |
||
| E09P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Monkey Pan cytokeratin ELISA kit |
||
| E09P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Monkey Pan cytokeratin ELISA kit |
||
| E09P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rabbit Polyclonal antibody Anti-CRBN |
||
| Anti-CRBN | 50 µg | EUR 418.8 |
Anti-pan Cadherin Rabbit Monoclonal Antibody |
||
| M00063-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal pan Cadherin Antibody. Validated in IP, IF, IHC, WB and tested in Human, Mouse, Rat. |
||
Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody - With BSA and Azide, Clone: PAN-CK (Cocktail) |
||
| APR14619G | 0.05mg | EUR 475.2 |
|
Description: A Monoclonal antibody against Human Cytokeratin, pan (Epithelial Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone PAN-CK (Cocktail). This antibody is applicable in WB, IHC and IF, FC |
||
Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody - Without BSA and Azide, Clone: PAN-CK (Cocktail) |
||
| APR14623G | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Cytokeratin, pan (Epithelial Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone PAN-CK (Cocktail). This antibody is applicable in WB, IHC and IF, FC |
||
PCK antibody |
||
| 10R-7892 | 100 ug | EUR 386.4 |
|
Description: Mouse monoclonal PCK antibody |
||
Anti-PCK Antibody (monoclonal, C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2) |
||
| MA1081 | 100ug/vial | EUR 400.8 |
Anti-Cytokeratin 15 Monoclonal Antibody |
||
| A06791-1 | 100ul | EUR 476.4 |
|
Description: Mouse Monoclonal Antibody for Cytokeratin 15 Antibody (KRT15) detection.tested for Flow Cytometry, IF, IHC, WB in Human. |
||
Anti-Cytokeratin 6 Monoclonal Antibody |
||
| A04012 | 100ul | EUR 476.4 |
|
Description: Mouse Monoclonal Antibody for Cytokeratin 6 Antibody (KRT6A) detection. Tested with WB in Human. |
||
Anti-Cytokeratin Antibody Clone PAN-CK (Cocktail), Unconjugated-100ug |
||
| MSM17-999-P1 | 100ug | EUR 513.6 |
Guinea pig Pan cytokeratin ELISA kit |
||
| E05P0622-192T | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Guinea pig Pan cytokeratin ELISA kit |
||
| E05P0622-48 | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Guinea pig Pan cytokeratin ELISA kit |
||
| E05P0622-96 | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Pan cytokeratin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Cytokeratin-pan (Acetyl Lys194) Polyclonal Antibody |
||
| ES1117-100ul | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cytokeratin-pan (Acetyl Lys194) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
||
Cytokeratin-pan (Acetyl Lys194) Polyclonal Antibody |
||
| ES1117-50ul | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cytokeratin-pan (Acetyl Lys194) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
||
Cytokeratin-pan (Acetyl Lys194) Polyclonal Antibody |
||
| ABP50118-003ml | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of Cytokeratin-pan Acetyl Lys194) from Human, Mouse, Rat. This Cytokeratin-pan Acetyl Lys194) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cytokeratin around the acetylation site of K194 |
||
Cytokeratin-pan (Acetyl Lys194) Polyclonal Antibody |
||
| ABP50118-01ml | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of Cytokeratin-pan Acetyl Lys194) from Human, Mouse, Rat. This Cytokeratin-pan Acetyl Lys194) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cytokeratin around the acetylation site of K194 |
||
Cytokeratin-pan (Acetyl Lys194) Polyclonal Antibody |
||
| ABP50118-02ml | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of Cytokeratin-pan Acetyl Lys194) from Human, Mouse, Rat. This Cytokeratin-pan Acetyl Lys194) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cytokeratin around the acetylation site of K194 |
||
Cytokeratin, Pan; Clones AE1 & AE3 (Concentrate) |
||
| A00152-C | 1 ml | EUR 596.4 |
Cytokeratin, Pan; Clones AE1 & AE3 (Concentrate) |
||
| A00152-C.1 | 0.1 ml | EUR 165.6 |
Cytokeratin-pan (Acetyl-Lys194) Polyclonal Antibody |
||
| HW128-100ul | 100ul | EUR 302.4 |
Cytokeratin-pan (Acetyl-Lys194) Polyclonal Antibody |
||
| HW128-50ul | 50ul | EUR 224.4 |
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V8321-100UG | 100 ug | EUR 499 |
|
Description: Anti-cytokeratin clone PCK/3150 demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, PCK/3150 is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, PCK/3150 is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V8321-20UG | 20 ug | EUR 219 |
|
Description: Anti-cytokeratin clone PCK/3150 demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, PCK/3150 is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, PCK/3150 is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V8321SAF-100UG | 100 ug | EUR 499 |
|
Description: Anti-cytokeratin clone PCK/3150 demonstrates a broad spectrum of cytokeratin reactivity. In normal tissues, PCK/3150 is reactive with most epithelial types, including bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, intestinal epithelium of stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin (positive on the basal layer and negative on the superficial layers of squamous epithelium), and apocrine and sweat glands. In tumors, PCK/3150 is reactive with most carcinomas, including breast, transitional cell (TCC), renal cell (RCC), lung adenocarcinoma, lung small cell, lung squamous cell, endometrial, prostate, ovarian, hepatocellular (HCC), colorectal CA, stomach and thyroid. It is negative in certain normal tissues, including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including most melanomas, sarcomas, lymphomas, primitive neuroectodermal tumors (PNET)/Ewings and gastrointestinal stromal tumors (GIST). Positivity has been seen on some dendritic cells in lymph nodes, some endothelia, and some muscle cells. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V2330-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This pan keratin antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3-6, CK8, CK10, CK14-16, and CK19. Many studies have shown the usefulness of keratin markers in cancer research and tumor diagnosis. The AE1 + AE3 antibody cocktail is a broad spectrum pan cytokeratin antibody cocktail which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of keratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. It stains cytokeratin present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V2330-20UG | 20 ug | EUR 219 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This pan keratin antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3-6, CK8, CK10, CK14-16, and CK19. Many studies have shown the usefulness of keratin markers in cancer research and tumor diagnosis. The AE1 + AE3 antibody cocktail is a broad spectrum pan cytokeratin antibody cocktail which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of keratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. It stains cytokeratin present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V2330FITC-100T | 100 Tests | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. AE-1/AE-3 is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V2330IHC-7ML | 7 ml | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This pan keratin antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3-6, CK8, CK10, CK14-16, and CK19. Many studies have shown the usefulness of keratin markers in cancer research and tumor diagnosis. The AE1 + AE3 antibody cocktail is a broad spectrum pan cytokeratin antibody cocktail which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of keratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. It stains cytokeratin present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V2330PE-100T | 100 Tests | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This pan keratin antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3-6, CK8, CK10, CK14-16, and CK19. Many studies have shown the usefulness of cytokeratin markers in cancer research and tumor diagnosis. The AE1 + AE3 antibody cocktail is a broad spectrum pan cytokeratin antibody cocktail which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. It stains cytokeratin present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V2330SAF-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This pan keratin antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3-6, CK8, CK10, CK14-16, and CK19. Many studies have shown the usefulness of keratin markers in cancer research and tumor diagnosis. The AE1 + AE3 antibody cocktail is a broad spectrum pan cytokeratin antibody cocktail which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of keratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. It stains cytokeratin present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V7400-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V7400-20UG | 20 ug | EUR 219 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V7400IHC-7ML | 7 ml | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V7400SAF-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3051-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include Keratins 1, 3, 4, 5, 6, 8, 10, 14, 15, 16, and 19. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRTL/KRTH is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3051-20UG | 20 ug | EUR 219 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include Keratins 1, 3, 4, 5, 6, 8, 10, 14, 15, 16, and 19. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRTL/KRTH is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3051IHC-7ML | 7 ml | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include Keratins 1, 3, 4, 5, 6, 8, 10, 14, 15, 16, and 19. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRTL/KRTH is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3051SAF-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include Keratins 1, 3, 4, 5, 6, 8, 10, 14, 15, 16, and 19. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRTL/KRTH is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3070-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 55kDa (CK7); 52kDa (CK8); 56.5kDa (CK10); 53kDa (CK13); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 46kDa (CK17); 45kDa (CK18) and 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3070-20UG | 20 ug | EUR 219 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 55kDa (CK7); 52kDa (CK8); 56.5kDa (CK10); 53kDa (CK13); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 46kDa (CK17); 45kDa (CK18) and 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3070IHC-7ML | 7 ml | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 55kDa (CK7); 52kDa (CK8); 56.5kDa (CK10); 53kDa (CK13); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 46kDa (CK17); 45kDa (CK18) and 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3070SAF-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 55kDa (CK7); 52kDa (CK8); 56.5kDa (CK10); 53kDa (CK13); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 46kDa (CK17); 45kDa (CK18) and 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3490-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody detects acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins: 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3490-20UG | 20 ug | EUR 219 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody detects acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins: 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3490IHC-7ML | 7 ml | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody detects acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins: 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V3490SAF-100UG | 100 ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody detects acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins: 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V8774-100UG | 100ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. AE-1/AE-3 is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V8774-20UG | 20ug | EUR 219 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. AE-1/AE-3 is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V8774SAF-100UG | 100ug | EUR 499 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8); 56.5kDa (CK10); 50kDa (CK14); 50kDa (CK15); 48kDa (CK16); 40kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. AE-1/AE-3 is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Pan Cytokeratin Antibody Cocktail (Acidic + Basic) |
||
| V8774PE-100T | 100 Tests | EUR 349.3 |
|
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3, CK4, CK5, CK6, CK8, CK10, CK14, CK15, CK16, and CK19. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. This MAb is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas. |
||
Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody, Clone: AE-1/AE-3 |
||
| APR14634G | 0.1 ml at 0.1mg/ ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Cytokeratin, pan (Epithelial Marker). The antibodies are raised in Mouse and are from clone AE-1/AE-3. This antibody is applicable in IF, FC |
||
Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody, Clone: AE-1/AE-3 |
||
| APR14635G | 7 ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Cytokeratin, pan (Epithelial Marker). The antibodies are raised in Mouse and are from clone AE-1/AE-3. This antibody is applicable in WB, IHC and IF, FC |
||
Monoclonal Cytokeratin, pan (Epithelial Marker) Antibody, Clone: KRTL/1077 + KRTH/1076 |
||
| APR14637G | 7 ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Cytokeratin, pan (Epithelial Marker). The antibodies are raised in Mouse and are from clone KRTL/1077 + KRTH/1076. This antibody is applicable in IHC-P, IF, FC |
||
Anti-Pan-Cadherin Antibody (monoclonal, CH-19) |
||
| MA1079 | 100ug/vial | EUR 400.8 |
Anti-Histone H3 pan, Rabbit Monoclonal Antibody |
||
| A1141-25 | each | EUR 314.4 |
Monoclonal AKT(pan) Antibody |
||
| APG01675G | 0.1ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human AKT(pan). The antibodies are raised in Mouse. This antibody is applicable in WB, IP |
||
Monoclonal AKT(pan) Antibody |
||
| APG01676G | 0.1ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human AKT(pan). The antibodies are raised in Mouse. This antibody is applicable in WB |
||
Mouse Anti Human Cytokeratin Monoclonal Antibody |
||
| DMABT-52180MH | 0.5 ml | EUR 1450.8 |
Anti-Cytokeratin 18 (KRT18) Monoclonal Antibody |
||
| M01357 | 100ug/vial | EUR 476.4 |
|
Description: Mouse Monoclonal Cytokeratin 18 (KRT18) Antibody. Validated in IHC and tested in Bovine, Canine, Equine, Goat, Hamster, Human, Monkey, Mouse, Pig, Rat. |
||
Anti-Cytokeratin 18 Rabbit Monoclonal Antibody |
||
| M01357-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 18 Antibody. Validated in IF, WB and tested in Human. |
||
Anti-Cytokeratin 18 Rabbit Monoclonal Antibody |
||
| M01357-2 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 18 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat. |
||
Anti-Cytokeratin 18 Antibody (monoclonal, 7I6) |
||
| M01357-4 | 100ug/vial | EUR 400.8 |
Anti-Cytokeratin 8 Rabbit Monoclonal Antibody |
||
| M01421-2 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 8 Antibody. Validated in IP, IF, IHC, WB and tested in Human, Mouse. |
||
Anti-Cytokeratin 8 Antibody (monoclonal, 3G9) |
||
| M01421-3 | 100ug/vial | EUR 400.8 |
Anti-Cytokeratin 14 Rabbit Monoclonal Antibody |
||
| M01432-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 14 Antibody. Validated in IP, IF, WB and tested in Human. |
||
Anti-Cytokeratin 14 Rabbit Monoclonal Antibody |
||
| M01432-2 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 14 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat. |
||
Anti-Cytokeratin 1 Rabbit Monoclonal Antibody |
||
| M01639 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 1 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
||
Anti-Cytokeratin 1 Rabbit Monoclonal Antibody |
||
| M01639-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 1 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
||
Anti-Cytokeratin 19 Rabbit Monoclonal Antibody |
||
| M02101-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 19 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse. |
||
Anti-Cytokeratin 19 Antibody (monoclonal, 3D4) |
||
| M02101-2 | 100ug/vial | EUR 400.8 |
Anti-Cytokeratin 17 Rabbit Monoclonal Antibody |
||
| M02289-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 17 Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
||
Anti-Cytokeratin 10 Rabbit Monoclonal Antibody |
||
| M02305-1 | 100ug/vial | EUR 476.4 |
|
Description: Anti-Cytokeratin 10 Rabbit Monoclonal Antibodytested for IF, IHC, ICC, WB in Human, Mouse, Rat |
||
Anti-Cytokeratin 7 Rabbit Monoclonal Antibody |
||
| M02416-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 7 Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
||
Anti-Cytokeratin 7 Rabbit Monoclonal Antibody |
||
| M02416-2 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 7 Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
||
Anti-Cytokeratin 20 Rabbit Monoclonal Antibody |
||
| M02828 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 20 Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC, WB and tested in Human, Rat. |
||
Anti-Cytokeratin 16 Rabbit Monoclonal Antibody |
||
| M03393 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 16 Antibody. Validated in Flow Cytometry, IF, IHC, ICC, WB and tested in Human. |
||
Anti-Cytokeratin 9 Rabbit Monoclonal Antibody |
||
| M03692 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 9 Antibody. Validated in IP, WB and tested in Human, Mouse, Rat. |
||
Anti-Cytokeratin 13 Rabbit Monoclonal Antibody |
||
| M04299 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 13 Antibody. Validated in IF, WB and tested in Human, Mouse. |
||
Anti-Cytokeratin 2e Rabbit Monoclonal Antibody |
||
| M05667 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 2e Antibody. Validated in WB and tested in Human. |
||
Anti-Cytokeratin 15 Rabbit Monoclonal Antibody |
||
| M06791-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 15 Antibody. Validated in IF, WB and tested in Human, Mouse. |
||
Anti-Cytokeratin 4 Rabbit Monoclonal Antibody |
||
| M07410 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 4 Antibody. Validated in IF, WB and tested in Human, Rat. |
||
Anti-Cytokeratin 4 Rabbit Monoclonal Antibody |
||
| M07410-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 4 Antibody. Validated in IP, IF, WB and tested in Human. |
||
Anti-Cytokeratin 6 Rabbit Monoclonal Antibody |
||
| M30943-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 6 Antibody. Validated in WB and tested in Human. |
||
Anti-Cytokeratin 5/8 Monoclonal Antibody |
||
| M00398 | 100ug/vial | EUR 476.4 |
|
Description: Mouse Monoclonal Cytokeratin 5/8 Antibody. Validated in IHC and tested in Bovine, Canine, Hamster, Human, Mouse, Pig, Rat. |
||
Anti-Cytokeratin 5 Rabbit Monoclonal Antibody |
||
| M00398-1 | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 5 Antibody. Validated in IF, WB and tested in Human. |
||
Anti-Cytokeratin 5, Rabbit Monoclonal Antibody |
||
| A1136-50 | each | EUR 392.4 |
Anti-Cytokeratin-8 Rabbit Monoclonal Antibody |
||
| A1608-50 | each | EUR 444 |
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNC941835-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),CF594 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNC941835-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),CF594 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNCA0371-250 | 250uL | EUR 459.6 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), APC conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNCA1100-250 | 250uL | EUR 459.6 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), APC conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNCA1835-250 | 250uL | EUR 459.6 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),APC conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNCAP0371-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNCAP0371-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNCAP1100-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNCAP1100-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNC551835-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),CF555 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNC551835-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),CF555 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNC610371-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), CF660R conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNC610371-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), CF660R conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNC611100-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), CF660R conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNC611100-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), CF660R conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNC611835-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),CF660R conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNC611835-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),CF660R conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNC680371-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), CF568 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNC680371-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), CF568 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNUM1100-50 | 50uL | EUR 474 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), 1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNUM1835-50 | 50uL | EUR 474 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A), 1mg/mL |
||
Human pan-cytokeratin,P-CK ELISA Kit |
||
| CN-04386H1 | 96T | EUR 542.4 |
Human pan-cytokeratin,P-CK ELISA Kit |
||
| CN-04386H2 | 48T | EUR 362.4 |
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNCP1835-250 | 250uL | EUR 459.6 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),PerCP conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNCR0371-250 | 250uL | EUR 459.6 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), RPE conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNCR1100-250 | 250uL | EUR 459.6 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), RPE conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan (Epithelial Marker) (N/A) Antibody |
||
| BNCR1835-250 | 250uL | EUR 459.6 |
|
Description: Primary antibody against Cytokeratin, pan (Epithelial Marker)(N/A),RPE conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNUB0371-100 | 100uL | EUR 250.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), Concentration: 0.2mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNUB0371-500 | 500uL | EUR 549.6 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), Concentration: 0.2mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNUB1100-100 | 100uL | EUR 250.8 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), Concentration: 0.2mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNUB1100-500 | 500uL | EUR 549.6 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), Concentration: 0.2mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNC430371-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), CF543 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(AE-1 / AE-3) Antibody |
||
| BNC430371-500 | 500uL | EUR 652.8 |
|
Description: Primary antibody against Cytokeratin, pan(AE-1 / AE-3), CF543 conjugate, Concentration: 0.1mg/mL |
||
Cytokeratin pan(KRTL/1077 + KRTH/1076) Antibody |
||
| BNC431100-100 | 100uL | EUR 238.8 |
|
Description: Primary antibody against Cytokeratin, pan(KRTL/1077 + KRTH/1076), CF543 conjugate, Concentration: 0.1mg/mL |
||